Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
Breast cancer, lymph node metastatic carcinoma and adjacent normal tissue array, including pathology grade, TNM and clinical stage, 100 cases/100 cores, replacing BR1008
BR1008a
BioCoreUSA row: 10; column: 10; cores: 100; cases: 100
Colon cancer tissue/matched normal tissue array with survival data, including survival status, pathology grade, TNM and clinical stage, 80 cases/160 cores
Colon cancer tissue/matched normal tissue array with survival data, including survival status, pathology grade, TNM and clinical stage, 80 cases/160 cores
S-CRAC3204M
BioCoreUSA row: 10; column: 16; cores: 160; cases: 80
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
Different stages bladder cancer tissue array with matched adjacent normal or cancer adjacent tissue, including pathology grade, TNM and clinical stage, 27 cases/54 cores
UBD541
BioCoreUSA row: 7; column: 8; cores: 54; cases: 27
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
Breast cancer tissue array with matched adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251
FMG251a
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 47 cases/80 cores, replacing BR802
Breast invasive ductal carcinoma with matched or unmatched adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 47 cases/80 cores, replacing BR802
BR802b
BioCoreUSA row: 8; column: 10; cores: 80; cases: 47
Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores
Breast cancer and breast tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical stage, 96 cases/100 cores
FMG1001
BioCoreUSA row: 10; column: 10; cores: 100; cases: 96
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
Bladder cancer tissue array with matched cancer adjacent tissue, including pathology grade, TNM and clinical stage, 10 cases/24 cores, replacing BL241
BL241a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 10
Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade,TNM and clinical stage, 45 cases/63 cores
Breast cancer tissue array, with adjacent normal tissue and cancer adjacent breast tissue, including pathology grade,TNM and clinical stage, 45 cases/63 cores
FMG631
BioCoreUSA row: 7; column: 9; cores: 63; cases: 45
Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores
Breast cancer tissue array with adjacent normal breast tissue, including pathology grade, TNM and clinical stage, 75 cases/150 cores
FMG1504
BioCoreUSA row: 10; column: 15; cores: 150; cases: 75
Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade and IHC markers (ER, Her-2), TNM and clinical stage, 102 cases/102 cores
Multiple types breast cancer tissue array with adjacent normal tissue, including pathology grade and IHC markers (ER, Her-2), TNM and clinical stage, 102 cases/102 cores
FMG1021
BioCoreUSA row: 8; column: 13; cores: 102; cases: 102
Breast carcinoma (Her2 3+) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 70 cases/140 cores.
Breast carcinoma (Her2 3+) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 70 cases/140 cores.
S-FMG140M
BioCoreUSA row: 12; column: 12; cores: 140; cases: 70
Breast carcinoma (HR) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.
Breast carcinoma (HR) tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage, 71 cases/142 cores.
S-FMG142M
BioCoreUSA row: 11; column: 14; cores: 142; cases: 71
Breast cancer tissue array with adjacent normal tissue, including pathology gradeand and IHC marker (ER, PR Ki-67and Her-2), TNM and clinical stage, 6 cases/24 cores
Breast cancer tissue array with adjacent normal tissue, including pathology gradeand and IHC marker (ER, PR Ki-67and Her-2), TNM and clinical stage, 6 cases/24 cores
FMG247
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma
Kidney cancer tissue array with matched normal adjacent tissue and metastatic carcinoma
KD951a
TissueArray each
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (1 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20832
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (2 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20833
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (3 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20834
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
Breast tumor survey tissue array (4 of 5), with adjacent normal tissue, including pathology grade, TNM and clinical stage, 208 cases/208 cores
BR20835
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Non-small cell lung cancer tissue array with survival data, including pathology grade, TNM and clinical stage, 120 cases/120 cores
Non-small cell lung cancer tissue array with survival data, including pathology grade, TNM and clinical stage, 120 cases/120 cores
S-LUC2401M
BioCoreUSA row: 10; column: 12; cores: 120; cases: 120
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM and clinical stage, 72 cases/72 cores, replacing FMG08013e
FMG08013f
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 120 cases/ 132 cores
Breast cancer tissue array with lymph node positive and negative, with cancer adjacent tissue, including pathology grade, TNM and clinical stage, 120 cases/ 132 cores
BR1321
BioCoreUSA row: 12; column: 11; cores: 132; cases: 120
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
Breast cancer with adjacent normal breast tissue array, including pathology grade, TNM, clinical stage and IHC marker (ER, PR, Her2, Ki-67) results, 72 cases/72 cores, replacing BC08013d
FMG08013e
BioCoreUSA row: 8; column: 9; cores: 72; cases: 72
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
Multiple bladder cancer with bladder tissue array, with metastatic carcinoma, including pathology grade, TNM and clinical satge, 64 cases/192 cores, replacing BL208
UBD208a
BioCoreUSA row: 12; column: 16; cores: 192; cases: 64
Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245a
Breast cancer with adjacent normal tissue array (2012 WHO classification), including pathology grade, TNM and clinical stage (AJCC 7th edition), 12 cases/24 cores, repalcing BR245a
FBR-245b
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Brain tumor tissue array with matched cancer adjacent or adjacent normal tissue, including pathology grade, 35 cases/80 cores
Brain tumor tissue array with matched cancer adjacent or adjacent normal tissue, including pathology grade, 35 cases/80 cores
NCT808
BioCoreUSA row: 8; column: 10; cores: 80; cases: 35
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 50 cases/100 cores
FMG1009
BioCoreUSA row: 10; column: 10; cores: 100; cases: 50
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
FMG809
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Breast cancer with matched breast tissue array, including  pathology grade, TNM and clinical stage, 12 cases/24 cores
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores
FMG252
BioCoreUSA row: 4; column: 6; cores: 24; cases: 12
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue
Colorectal cancer tissue array with matched normal adjacent and metastatic carcinoma tissue
CO952a
TissueArray each
Triple negative breast tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage , 62 cases/133 cores
Triple negative breast tissue array with survival data, including prognosis, pathology grade, TNM and clinical stage , 62 cases/133 cores
S-FMG133M
BioCoreUSA row: 10; column: 14; cores: 133; cases: 62
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores
Breast cancer tissue array with normal breast tissue, including pathology grade, TNM, clinical stage and Her-2 results, 5 cases/5 cores
BRC051
BioCoreUSA row: 1; column: 5; cores: 5; cases: 5
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251c
BR251d
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer with matched breast tissue array, including  pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
Breast cancer with matched breast tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing BR251b
FMG251c
BioCoreUSA row: 3; column: 8; cores: 24; cases: 6
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/24 cores, replacing BR248
BR248a
BioCoreUSA row: 4; column: 6; cores: 24; cases: 24
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483
FMG483b
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
Breast cancer tissue array with normal tissue, including pathology grade, TNM and clinical stage, 48 cases/48 cores, replacing BR483b
FMG483c
BioCoreUSA row: 6; column: 8; cores: 48; cases: 48
Middle-advanced stage breast cancer tissue array, with metastasis tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
Middle-advanced stage breast cancer tissue array, with metastasis tissue, including pathology grade, TNM and clinical stage, 80 cases/80 cores
BR8017
BioCoreUSA row: 8; column: 10; cores: 80; cases: 80
Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124a
Bladder cancer tissue array with normal bladder tissue, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T124a
UBD243
BioCoreUSA row: 3; column: 8; cores: 24; cases: 12
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
Breast cancer with matched or unmatched breast tissue array, including pathology grade, TNM and clinical stage, 54 cases/80 cores, replacing BR802b
FMG802c
BioCoreUSA row: 8; column: 10; cores: 80; cases: 54
Triple negative breast cancer with normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 112 cases/112 cores
Triple negative breast cancer with normal tissue array, including pathology grade, TNM, clinical stage and IHC markers (ER, PR, Her-2), 112 cases/112 cores
BRE1121
BioCoreUSA row: 10; column: 12; cores: 112; cases: 112
Adrenal gland tumor tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/48 cores
Adrenal gland tumor tissue array with normal tissue, including pathology grade, TNM and clinical stage, 24 cases/48 cores
EAG481
BioCoreUSA row: 6; column: 8; cores: 48; cases: 24
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue
Lung cancer tissue array with matched metastatic carcinoma and cancer adjacent tissue
LC953
TissueArray each
Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores
Bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 27 cases/81 cores
UBD812
BioCoreUSA row: 9; column: 9; cores: 81; cases: 27
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
Bladder cancer tissue array with adjacent normal tissue, including TNM and clinical stage, 24 cases/72 cores
UBD721
BioCoreUSA row: 8; column: 9; cores: 72; cases: 24
Breast cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 208 cases/208 cores
Breast cancer survey tissue array (5 of 5), including TNM, clinical stage and pathology grade, 208 cases/208 cores
BR20836
BioCoreUSA row: 13; column: 16; cores: 208; cases: 208
Breast invasive carcinoma tissue array, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores
Breast invasive carcinoma tissue array, including pathology grade, TNM and clinical stage, 10 cases/ 10 cores
PM2b-ER
BioCoreUSA row: 3; column: 4; cores: 10; cases: 10
Urothelial carcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores
Urothelial carcinoma tissue array, including pathology grade, TNM and clinical stage, 64 cases/64 cores
UBD641
BioCoreUSA row: 8; column: 8; cores: 64; cases: 64
Multiple of bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 90 cases/90 cores
Multiple of bladder cancer tissue array with bladder tissue, including pathology grade, TNM and clinical stage, 90 cases/90 cores
UBD902
BioCoreUSA row: 9; column: 10; cores: 90; cases: 90
Breast cancer and normal tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores
Breast cancer and normal tissue array, including pathology grade, TNM and clinical stage, 2 serial sections, 48 cases/96 cores
BR485
BioCoreUSA row: 6; column: 16; cores: 96; cases: 48
Breast cancer survey tissue array (22 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores
Breast cancer survey tissue array (22 of 25), including pathology grade, TNM and clinical stage, 104 cases/208 cores
BR20828
BioCoreUSA row: 13; column: 16; cores: 208; cases: 104